The prognosis of people with<unk>  is generally good, as is quality of life, given very good treatment. Monitoring of a person with<unk>  is very important, as at least 20% of people diagnosed with it will experience a<unk>  crisis within two years of their diagnosis, requiring rapid medical intervention. Generally, the most disabling period of<unk>  might be years after the initial diagnosis. In the early 1900s, 70% of detected cases died from lung problems; now, that number is estimated to be around 3–5%, which is attributed to increased awareness and medications to manage symptoms.
Myasthenia gravis
Guillain–Barré syndrome
Congenital myasthenic syndrome
Botulism
Neurasthenia
Organophosphate poisoning
Polymyositis
Brainstem stroke syndrome